07-09-2021, 02:01 PM
Quote:Takeda, Japan's biggest drugmaker, is preparing to make the vaccine domestically and will distribute it in early 2022, pending approval from regulators, the company said in a statement. The TAK-019 vaccine is still undergoing clinical trials in Japan, according to Takeda.
Japan should be getting theirs next year pending approval.